- Home
- Platforms
- GlycoNano™ Platform
- Glycol Nanorod
Glycol Nanorod Production Service
Overview
The current research on glycol nanorods is primarily centered around the comprehensive exploration and meticulous optimization of their synthesis methods. The aim is to achieve more precise size control, meticulous morphology tuning, and the production of high-purity preparations. This involves delving deep into various aspects such as the selection and manipulation of reaction conditions, the utilization of novel catalysts, and the development of advanced processing techniques. In terms of material properties, researchers have conducted an in-depth and exhaustive investigation into the physicochemical properties of glycol nanorods. This encompasses not only surface charge, hydrophilicity, and optical properties but also other crucial characteristics such as thermal stability, mechanical strength, and electrical conductivity. These comprehensive studies provide a profound understanding of the intrinsic nature and potential application scenarios of glycol nanorods.
Glycol Nanorod Production Service: Redefining Nanoscale Possibilities
CD BioGlyco has been actively engaged and dedicatedly working in the highly specialized and advanced field of sugar nanotechnology for a considerable number of years. We possess a comprehensive and sophisticated GlycoNano™ Platform that integrates cutting-edge technologies and innovative research approaches. This platform is not only well-structured but also equipped with state-of-the-art facilities and a team of highly skilled professionals, enabling us to conduct in-depth studies and make significant breakthroughs in this domain. Based on our cutting-edge platform, we provide a variety of nanomaterials R&D services, covering but not restricted to the development and production of Glyconanoparticle, Glycol Nanohydrogel, Glycol Nanotube, and glycol nanorods. The glycol nanorods, especially gold nanorods (AuNRS) included in our service are as follows:
- Galactose-based Polymer-Containing AuNRS
- AuNRS-PEG-PCL
- AuNRS-PEG-PLA
- AuNRS-PEG-PLGA
- AuNRS-PEG-Silane
- AuNRS-PEG-ALK
- AuNRS-PEG-Cholesterol
- AuNRS-PEG-DSPE
- AuNRS-PEG-RB on the end
- AuNRS-PEG-FITC
- AuNRS-PEG-OPSS
- AuNRS-PEG-FA
- AuNRS-PEG-Azide
- AuNRS-PEG-Biotin
- AuNRS-PEG-NHS
- AuNRS-PEG-MAL
- AuNRS-PEG-SH
- AuNRS-PEG-NH2
- AuNRS-PEG-COOH
- AuNRS-mPEG
Workflow
Preparation of AuNRS
First, we heat the chloroauric acid (HAuCl4) solution to boiling, quickly add sodium citrate solution, and continue boiling for some time to obtain the gold nanoseed solution. Subsequently, we prepare the growth solution by mixing a certain amount of chloroauric acid, silver nitrate, cetyltrimethylammonium bromide (CTAB), and ascorbic acid. The prepared seed solution was added to the growth solution and left at a certain temperature for some time to grow the AuNRS. Finally, unreacted substances and impurities were removed by centrifugation, washing, and other operations to obtain pure AuNRS.
Surface Modified with PEG
We chemically attach PEG to the surface of AuNRS to enhance their water solubility and biocompatibility. Firstly, one end of the PEG molecule is activated to introduce functional groups, such as sulfhydryl, which can react with the surface of AuNRS. Subsequently, the activated PEG solution is mixed with the AuNRS solution. The reaction is promoted by stirring or oscillation under appropriate temperature and pH conditions. After the reaction is accomplished, the unreacted PEG and other impurities are eliminated by centrifugation, dialysis, or filtration to obtain the PEG-modified AuNRS.
Joining of Different Polymers
Our experts perform functional group activation of the polymers to be joined, depending on the properties of the polymers to be joined. For example, in the case of PCL, we introduce reactive groups such as carboxyl or amino groups at its end. The activated polymer functional groups are used to react chemically with the active sites on the surface of the PEG-modified AuNRS.

Applications
- In biosensing, they can specifically recognize biomolecules and provide a sensitive means for disease detection.
- In materials science, glycol nanorods can be used as the basic unit for constructing new composite materials and improving the properties of materials.
- In the field of biomedicine, glycol nanorods act as a drug carrier. By their unique structure and properties, glycol nanorods can accurately encapsulate and load drugs to ensure that the drugs can accurately and precisely reach the lesion site, thus realizing highly accurate drug delivery.
Advantages
- We perform precise chemical modifications on the surface of glycol nanorods to enhance their interactions with other substances or to confer new functions.
- Our experts integrate multiple functions into glycol nanorods based on your needs, such as simultaneous drug delivery and imaging capabilities.
- We optimize the production conditions in multiple manners and endeavor to produce glycol nanorods that are stable and effective in complex physiological or chemical circumstances.
Publication Data
Journal: Biosensors
Published: 2020
IF: 4.9
Results: This article focuses on the use of AuNRS in localized surface plasmon resonance (LSPR) biosensing, including their synthesis, techniques for silicon coating, and bioanalytical applications. A thiol-modified poly(vinyl alcohol) (mPEG-SH) is mentioned in the paper, which plays an important role in binding to AuNRs. mPEG-SH promotes the nucleation and growth of the silica shell layer by strongly interacting with the gold surface. In biosensing applications, the use of mPEG-SH helps to improve the biocompatibility and stability of AuNRS, while enhancing the sensitivity and selectivity of the sensors by binding to biomolecules such as antibodies. The PEGylation/Stöber process mentioned in the paper enables the formation of a non-porous silica shell layer in a short reaction time, which is crucial for the performance of the biosensor.
Fig.1 The substitution of CTAB with mPEG-SH for silica growth and the subsequent porosity induction along with the corresponding TEM images. (Pellas, et al., 2020)
Frequently Asked Questions
- To what extent is the stability of glycol nanorods maintained in various environments (such as acidic and alkaline ones)?
In general, the stability depends on the chemical composition of the nanorods, the surface modifications, and the specific conditions of the environment (e.g., strength of acidity or alkalinity, temperature, etc.). If the surface is not adequately protected by an acid-resistant coating or chemical modification, acidic conditions might give rise to structural alterations in the nanorods, such as the breakage of chemical bonds and the change of surface charge, etc., which could reduce their stability. Glycol nanorods may be able to maintain better stability at weaker alkaline conditions. However, in strongly alkaline environments, structural damage and property changes similar to those in acidic environments may also occur. -
What is the role of glycol nanorods in nanocomposites?
Glycol nanorods are capable of enhancing the barrier performance by forming a barrier layer to prevent the permeation of gases, liquids, or small molecules. If specific active sites exist on the surface of the nanorods, they can act as catalysts in chemical reactions to enhance efficiency and selectivity. Moreover, they can be endowed with functionality, such as being utilized in sensing materials to increase detection sensitivity and achieving the controlled release of drugs in the field of biopharmaceuticals, and so forth.
At CD BioGlyco, our team of highly skilled professionals is dedicated to delivering top-quality glycol nanorods that meet your specific requirements. We utilize advanced manufacturing techniques and state-of-the-art facilities to ensure the precision and uniformity of the produced nanorods. Contact us and let us be your trusted partner to help you achieve your goals related to glycol nanorods.
Reference
- Pellas, V.; et al. Gold nanorods for LSPR biosensing: synthesis, coating by silica, and bioanalytical applications. Biosensors. 2020, 10(10): 146.
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform





